Cardiology

Self-expanding TAVR widens advantage over surgery at two years

Two-year data show a continued survival advantage for self-expanding transcatheter aortic valve replacement (TAVR) over standard surgery in high-risk patients with severe aortic stenosis, according to research presented at ...

Cardiology

Aortic valve replacement beats no surgery at all

A minimally invasive procedure to replace the aortic valve without doing open heart surgery has better outcomes after five years than patients who did not have surgery at all, researchers said Sunday.

Cardiology

Results of PARTNER I trial reported at TCT 2014

New data from a landmark clinical trial found that after five years, transcatheter aortic valve replacement (TAVR) demonstrated a persistent mortality benefit, improved functional status, and resulted in a lower rate of repeat ...

Cardiology

Results of US CoreValve High Risk Trial reported at TCT 2014

According to a new study, transcatheter aortic valve replacement (TAVR) provided meaningful clinical benefits relative to surgical aortic valve replacement (SAVR) in high risk patients with incremental costs considered acceptable ...

Cardiology

Results of CLEAN-TAVI trial reported at TCT 2014

A first-of-its kind study found that using a cerebral protection device during transcatheter aortic valve replacement (TAVR) can significantly reduce the number and volume of cerebral lesions in high risk patients with severe ...

page 4 from 7